Quest Diagnostics
DGX
#1152
Rank
$15.43 B
Marketcap
$138.96
Share price
0.55%
Change (1 day)
0.12%
Change (1 year)
Quest Diagnostics is an American clinical laboratory company offering access to diagnostic testing services for cancer, cardiovascular disease, infectious disease, neurological disorders and employment and court ordered drug testing.

Earnings for Quest Diagnostics (DGX)

Earnings in 2023 (TTM): $1.13 B

According to Quest Diagnostics 's latest financial reports the company's current earnings (TTM) are $1.11 B. In 2022 the company made an earning of $1.23 B a decrease over its 2021 earnings that were of $2.59 B.The earnings displayed on this page is the company's Pretax Income.

Earnings history for Quest Diagnostics from 2001 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) $1.13 B-8.5%
2022 $1.23 B-52.48%
2021 $2.59 B37.95%
2020 $1.88 B75.09%
2019 $1.07 B16.2%
2018 $0.92 B-10.1%
2017 $1.03 B-5.16%
2016 $1.08 B-1.54%
2015 $1.10 B31%
2014 $0.84 B-37.52%
2013 $1.34 B26.93%
2012 $1.06 B24.01%
2011 $0.85 B-27.7%
2010 $1.18 B-3.55%
2009 $1.22 B19.59%
2008 $1.02 B12.54%
2007 $0.91 B-11.7%
2006 $1.03 B13.49%
2005 $0.91 B9.02%
2004 $0.83 B13.19%
2003 $0.73 B36.03%
2002 $0.54 B63.07%
2001 $0.33 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
$0.78 B-29.42%๐Ÿ‡บ๐Ÿ‡ธ USA
$41.68 M-96.28%๐Ÿ‡บ๐Ÿ‡ธ USA
-$3.48 M-100.31%๐Ÿ‡บ๐Ÿ‡ธ USA
-$85.8 M-107.67%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.47 B-57.77%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
-$9.61 M-100.86%๐Ÿ‡บ๐Ÿ‡ธ USA